Advisory Board and Editors Toxicology

Journal Factsheet
A one-page PDF to help when considering journal options with co-authors
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
View author feedback

Cristina W Nogueira

Associate professor at Federal University of Santa Maria, Brazil. My current research interests center around the pharmacology and toxicology of organochalcogen compounds. Scopus researcher award/2010.

Jörg Oehlmann

Graduated as Dr. rer. nat. at University Münster in 1994. Habilitation at the International Graduate School Zittau in 1998. 2001-2004: Full professor (C3) for Ecology and Evolutionary Biology at Goethe University Frankfurt. Since 2004 full professor (C4) for Aquatic Ecotoxicology at Goethe University Frankfurt.

Head of the Department Aquatic Ecotoxicology and the Master's Programme in Environmental Sciences at Goethe University.

Primary research interests: Biological effects monitoring, endocrine active chemicals, pharmaceuticals and personal care products in the environment, effects of microplastics on aquatic organisms, development of an integrated water resource management.

Sonia MR Oliveira

Doctor Sonia Oliveira holds a Licenciatura in Biology (pre-Bologna) and a Master in Cellular and Molecular Biology from the University of Aveiro, where she also specialized in medicinal plants, toxicology, murine models, and spermatogenesis. In 2011 she moved to Australia to work in Reproductive Biological Sciences. She later explored the nerve-cancer connection in Cancer, namely in female cancers, and completed her Ph.D. in Human Physiology ( with a significant component in Medical Biochemistry and Neurophysiology) from the University of Newcastle (Australia) in 2018. She then worked with biomimetic systems and nanotechnology in diabetes and stem cells. She explored multiple methods for primary and secondary cell culture, always with a keen interest in histopathology, cell biology, and rare disorders. Participated in >40 event(s). (Co-)Supervised MSc dissertation(s) and final projects for course completion of LSc/BSc. And works mostly in the area(s) of Natural sciences with emphasis on Molecular and Cellular Biology, and Medical and Health Sciences with emphasis on Neurosciences, Cancer, Reproduction, Toxicology, Biotechnology, and Stem cells. Also has collaborations in Microbiology, Biomaterials, and Communication and Information technologies.

Timothy Omara

Dr. Timothy Omara is a researcher with the Institute of Chemistry of Renewable Resources, BOKU University, Austria. He is also an Assistant Lecturer of Chemistry at the Department of Chemistry, College of Natural Sciences, Makerere University, Uganda.

He was previously with the Department of Chemistry and Biochemistry, School of Sciences and Aerospace Studies, Moi University, Kenya, and affiliated with the Centre of Excellence II in Phytochemicals, Textile and Renewable Energy (PTRE) hosted at the same University.

Dr. Omara holds research assiduity and proven track record of publications and refereeing across international peer-reviewed journals, with research interests including-but not limited to- food toxicology, analytical, natural products and environmental chemistry employing advanced analytical techniques.

He has published over 80 peer-reviewed articles and 5 book chapters as of August 2025, and currently serves as an Academic Editor in PeerJ Life & Environment, PLoS ONE, PeerJ Analytical Chemistry, Journal of Food Quality (Wiley), Natural Product Communications (SAGE) and VEGETOS (Springer)

Thiago Parente

Scientist in Public Health at the Laboratory of Functional Genomics and Bioinformatics at the Oswaldo Cruz Institute (IOC, Fiocruz), Rio de Janeiro, Brazil. Scientific coordinator of the Institutional Bioinformatics Platform. CNPq Level 2 Research Productivity Scholar (Genetics). Permanent professor at the Graduate program on Systems and Computational Biology IOC, Fiocruz. Graduated in Biological Sciences - Genetics major - from the Federal University of Rio de Janeiro (2006), with a Master's degree in Cell and Molecular Biology from the IOC (2008) and PhD in Biophysics from UFRJ (2012). Through high performance technologies for DNA sequencing and computational data analysis, I investigate the effects of pollution on fauna, using fish as model organisms, and their responses and genetic adaptations to pollutants, especially those involved in the xenobiotic biotransformation system.

Worradorn Phairuang

Dr. Worradorn Phairuang is a Lecturer at Chiang Mai University, Thailand. His main research focuses on the chemical and physical characteristics of airborne nanoparticles. His interests cover all the natural and anthropogenic sources, particularly biomass burning including forest fire and agricultural residue burning. He is very interested in emission inventory from biomass burning in Thailand and Asian countries.

Alexandre Quintas

Dr. Alexandre Quintas is a Senior Associate Professor at Egas Moniz University, Lisbon, Portugal. He holds a PhD in Biological Chemistry.

Dr. Quintas' primary areas of research focus on tackling the
novel psychoactive substances issue, linking its use to neurodegenerative diseases.

David H. Reser

Lecturer, Behavioural and Systems Neuroscience Group, Department of Physiology. Founding Director and Inaugural President (2014-2015) of the Society for Claustrum Research.

Joao B.T. Rocha

Professor of Biochemical Toxicology at the Universidade Federal de Santa Maria-Department of Biochemistry and Molecular Biology CCNE, 97105-900, Santa Maria, RS, Brazil. Associate Regular Member of International Centre for Theoretical Physics, Trieste.

J. Thomas Sanderson

Professor of Toxicology at the INRS-Institut Armand-Frappier, Université du Québec, Laval, Canada. Adjunct professor at the Department of Pharmacology and Therapeutics, Faculty of Medicine, McGill University, Montréal, Canada. Member and former councillor (2008-2011) of the Society of Toxicology of Canada. Member of the Society of Toxicology since 2000. Recipient of a 2006 Leader's Opportunities Fund Infrastructure Award from the Canadian Foundation for Innovation. Current research funded by the Canadian Institutes of Health Research and Natural Sciences and Engineering Council of Canada.

Michael F Santillo

I have over a decade of experience leading independent laboratory research projects as a research chemist at the U.S. Food and Drug Administration (FDA). The focus of my work is using in silico (computational tools, especially QSAR) and in vitro (cellular and biochemical) methods for identifying chemical hazards associated with foods and dietary supplements.

Mirela Sedic

Dr Mirela Sedic (born Bauman) is Principal Scientist at the Institute for Anthropological Research Zagreb. She has authored over 50 scientific publications in peer-reviewed journals including high-impact journals such as BBA Molecular Basis of Disease, Molecular Cancer, The Journal of Pathology, Molecular Cancer Therapeutics, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Cancer Treatment Reviews.

She was the co-PI of international collaborative project with Functional Genomics Center Zurich in Switzerland (PRIME-XS-0000184 Proteomic profiling of retinal proteins from rat model of age-related macular degeneration 2012-2014) and the PI of the University of Rijeka grant “Screening and biological evaluation of acid ceramidase and sphingosine kinase inhibitors as a new class of anti-tumour agents” (2014 – 2017). She is currently the PI of the project funded by the Croatian Science Foundation “Dissecting the mechanisms of therapy resistance in BRAF-mutant colon cancer using an integrated –omics approach” (2019 – 2023) and the PI of the University of Rijeka research grant “Molecular features associated with BRAFV600E-mutated versus wild type BRAF colorectal cancer” (2019-2022). She is also the PI of the project No. 3238 - EPIC-XS 012: “Proteomic analysis of acquired resistance to vemurafenib in BRAF V600E–mutant colon cancer cells” (2019 - 2022) in collaboration with the Functional Genomics Center Zurich in Switzerland.